drugset / Trial / NCT00163748
Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is an open label pilot study of 40 evaluable patients receiving vinorelbine-gemcitabine combination chemotherapy with filgrastim support in an outpatient setting. Participating patients at the time of registration will have measurable relapsed or primary refractory lymphoma.
Timeline
- Start
- 2001-02
- Primary completion
- 2003-11
- Completion
- 2003-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Vinorelbine | Small molecule | — | — |